ST Pharm Co.,Ltd. (237690.KQ)
KRW 84900.0
(-4.61%)
KRW 84900.0
(-4.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 284.99 Billion | 249.32 Billion | 165.64 Billion | 124.1 Billion | 93.25 Billion | 97.73 Billion |
| Cost of Revenue | 178.36 Billion | 166.04 Billion | 111.72 Billion | 107.54 Billion | 96.05 Billion | 95.67 Billion |
| Gross Profit | 106.62 Billion | 83.28 Billion | 53.91 Billion | 16.56 Billion | -2.79 Billion | 2.05 Billion |
| Operating Expenses | 75.59 Billion | 65.42 Billion | 48.33 Billion | 35.37 Billion | 23.9 Billion | 17.7 Billion |
| Selling, General and Administrative Expenses | 44.74 Billion | 40.27 Billion | 31.09 Billion | 22.96 Billion | 9.49 Billion | 9.47 Billion |
| Research and Development Expenses | 30.84 Billion | 25.15 Billion | 17.24 Billion | 12.41 Billion | 14.41 Billion | 8.23 Billion |
| Other Expenses | - | 725.38 Million | 87.79 Million | 444.51 Million | - | - |
| Cost and Expenses | 253.95 Billion | 231.47 Billion | 160.06 Billion | 142.92 Billion | 119.96 Billion | 113.38 Billion |
| Operating Income | 31.03 Billion | 17.85 Billion | 5.57 Billion | -18.81 Billion | -26.7 Billion | -15.64 Billion |
| Interest Expense | 6.1 Billion | 2.86 Billion | 5.15 Billion | 644.58 Million | 78.87 Million | 970.00 |
| Income Tax Expense | 5.83 Billion | 1.72 Billion | -2.11 Billion | -3.67 Billion | -6.44 Billion | -4.12 Billion |
| Earnings before Tax | 23.35 Billion | 19.23 Billion | 1.26 Billion | -16.82 Billion | -24.97 Billion | -13.39 Billion |
| Net Income | 19.58 Billion | 18 Billion | 3.31 Billion | -12.14 Billion | -18.52 Billion | -9.26 Billion |
| Earnings Per Share Basic | 1041.07 | 957.00 | 177.50 | -651.11 | -993.18 | -496.78 |
| Earnings Per Share Diluted | 1041.07 | 957.00 | 177.50 | -651.11 | -993.18 | -496.78 |
| Weighted Average Shares Outstanding | 18.8 Million | 18.8 Million | 18.66 Million | 18.65 Million | 18.65 Million | 18.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.8 Million | 18.8 Million | 18.66 Million | 18.65 Million | 18.65 Million | 18.65 Million |
| Gross Margin | 0.37 | 0.33 | 0.33 | 0.13 | -0.03 | 0.02 |
| EBIT Margin | 0.18 | 0.14 | 0.12 | -0.04 | -0.17 | -0.07 |
| Profit Margin | 0.07 | 0.07 | 0.02 | -0.10 | -0.20 | -0.09 |
| EBITDA | 52.48 Billion | 39.7 Billion | 20.83 Billion | -2.11 Billion | -13.7 Billion | -6.41 Billion |
| Earnings Before Tax Margin | 0.11 | 0.07 | 0.03 | -0.15 | -0.29 | -0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 61.2 Billion | 44.58 Billion | 51.72 Billion | 284.99 Billion | 120.62 Billion | 55.94 Billion |
| Cost of Revenue | - | 30.57 Billion | 33.98 Billion | 178.36 Billion | 81.26 Billion | 33.39 Billion |
| Gross Profit | 61.2 Billion | 14.01 Billion | 17.73 Billion | 106.62 Billion | 39.36 Billion | 22.55 Billion |
| Operating Expenses | 57.1 Billion | 47.65 Billion | 15.85 Billion | 75.59 Billion | 17.88 Billion | 15.88 Billion |
| Selling, General and Administrative Expenses | - | 11.5 Billion | 11.42 Billion | - | 11.62 Billion | 10.18 Billion |
| Research and Development Expenses | - | 5.57 Billion | 4.43 Billion | - | 6.25 Billion | 5.7 Billion |
| Other Expenses | -57.1 Billion | -47.65 Billion | -49.84 Billion | -61.96 Million | 171.13 Million | -78.35 Million |
| Cost and Expenses | 57.1 Billion | 47.65 Billion | 49.84 Billion | 253.95 Billion | 99.14 Billion | 49.27 Billion |
| Operating Income | 4.09 Billion | -3.06 Billion | 1.87 Billion | 31.03 Billion | 21.48 Billion | 6.66 Billion |
| Interest Expense | - | - | - | 6.1 Billion | 9.93 Billion | 3.41 Billion |
| Income Tax Expense | 2.43 Billion | -19 Million | 2.08 Billion | 5.83 Billion | 3.33 Billion | 1.74 Billion |
| Earnings before Tax | 12 Billion | 885 Million | 7.5 Billion | 23.35 Billion | 13.39 Billion | 5.09 Billion |
| Net Income | 9.57 Billion | 1.01 Billion | 6.23 Billion | 19.58 Billion | 10.53 Billion | 3.93 Billion |
| Earnings Per Share Basic | 545.08 | 48.06 | 331.45 | - | 559.87 | 208.98 |
| Earnings Per Share Diluted | 545.08 | 48.06 | 331.45 | - | 559.87 | 208.98 |
| Weighted Average Shares Outstanding | 17.56 Million | 18.8 Million | 18.8 Million | 18.8 Million | 18.8 Million | 18.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.56 Million | 18.8 Million | 18.8 Million | 18.8 Million | 18.8 Million | 18.8 Million |
| Gross Margin | 1.00 | 0.31 | 0.34 | 0.37 | 0.33 | 0.40 |
| EBIT Margin | 0.07 | -0.07 | 0.15 | - | 0.23 | 0.23 |
| Profit Margin | 0.16 | 0.02 | 0.12 | 0.07 | 0.09 | 0.07 |
| EBITDA | 4.09 Billion | -3.06 Billion | 7.89 Billion | - | 27.53 Billion | 12.68 Billion |
| Earnings Before Tax Margin | 0.07 | -0.07 | 0.04 | 0.11 | 0.18 | 0.12 |
7544
BMY
EGIO
LAZR
002293
9600